Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

Ann Med Res. 1997; 4(4): 434-437


The procedures of treatment in esophagus carcinomas

 

Dr. Metin Aydın1, Dr. Osman Güler1, Dr. Muammer Karaayvaz1, Dr. Serdar Uğraş2

.




Abstract


 


Thirty patients with esophagus carcinoma were treated in Medical Faculty Hospital of Yüzüncü Yıl University between 1994 and 1996. Twenty cases were male and 10 cases were female. The median age was 43 (28-76). Dysphagia and weight lose were the most seen symptoms. Endoscopy and biopsy were essential diagnostic procedures. The most common site of tumor was the lower third of the esophagus (76.6%). The stage IIIpatients were 56.7% and stage II patients were 43.3%. Surgical resection was performed all of them except one patient. The mortality did not happen operatively. Postoperative chemotherapy was carried out all of them. We couldn't send the patients for radiotherapy because of the socioeconomic difficulties. In 13 cases, metastases were found in the first year and 8 of them died. Eight patients are still in remission. The mean follow up period is 16 months (5-23). In conclusion, in esophagus carcinoma, the most effective treatment is surgery even if curative or palliative. [Journal of Turgut Özal Medical Center 1997;4(4):434- 437]

Key Words: Esophagus, carcinoma, treatment








Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.